STUDY | DRUGS | DOSE AND DURATION | BEFORE TREATMENT | AFTER TREATMENT | P VALUE |
Cemil kaya (2009) | Atorvastatin | 20 mg OD *3 months | 14.3 ± 2.9 | 10.6 ± 1.7 | <0.01 |
Harmanci (2013) | Simvastatin | 20 mg OD *3 months | 13.6 ± 2.1 | 11.1 ± 1.9 | <0.05 |
Yilmaz (2005) | EE-DSRP + spironolactone | 3 mg/30 µg + 100 mg OD *6 months | 13.1 ± 5.2 | 17.6 ± 5.3 | <0.05 |
Cagnacci (2006) | Rosiglitazone | 4 mg OD*3 months | 13.94 ± 6.72 | 13.2 ± 5.88 | NS |
Gul OB (2008) | EE/DSG | 40/30 µg + 25/125 mg OD*6 months | 9.54 ± 0.7 | 9.8 ± 0.6 | NS |
| EE/CPA | 35 µg + 2 mg OD *6 months | 9.8 ± 1.9 | 7.9 ± 0.9 | <0.05 |
| EE/CPA | 35 µg + 2 mg OD *3 months | 55.97 ± 16.04 | 54.03 ± 16.15 | 0.001 |